Pharmaceutical composition using albumin as a carrier and process for producing the same |
| I claim: 1. A process for producing a pharmaceutical composition comprising mixing together at high ... |
|
Stabilized composition of levothyroxine sodium medication and method for its production |
| OF THE INVENTION The present invention discloses a new composition for levothyroxine sodium ... |
|
Liquisolid systems and methods of preparing same |
| OF THE DRAWINGS FIG. 1 is a schematic outline of steps involved in the preparation of liquisolid ... |
|
Stabilized medicaments containing thyroid hormones |
| We claim: 1. Stable medicaments containing thyroid hormones, wherein said medicaments comprise ... |
|
Areca food additives and its foods |
| A series of eatable compounds for preparation areca food additive, which have an excellent effect ... |
|
Beverage compositions for human consumption |
| OF THE PRESENT INVENTION The present invention is based on a number of new discoveries and ... |
|
Therapeutic food composition and method to diminish blood sugar fluctuations |
| Blood glucose levels in patients with diabetes mellitus are regulated and stabilized by ... |
|
|
Stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20%
| Details |
Inventors: Runge, Frank; Auweter, Helmut; Musaeus-Jensen, Nina; Haberkorn, Herbert; Rieger, Jens;
Assignee: BASF Aktiengesellschaft (Ludwigshafen)
Primary Examiner: Page; Thurman K.
Assistant Examiner: Pulliam; Amy
Attorney, Agent or Firm: Keil & Weinkauf
The invention relates to stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20%, processes for their preparation and their use as an additive to foodstuffs, cosmetics, pharmaceuticals and animal feedstuffs. |
|
DETAILED DESCRIPTION We claim: 1. A process for the preparation of stable, pulverulent lycopene formulations, comprising lycopene having a degree of crystallinity of greater than 20%, which comprises a) preparing a molecularly disperse solution of lycopene, if appropriate together with an emulsifier and/or an edible oil in a water-miscible, organic solvent or a mixture of water and a water-miscible, organic solvent at temperatures of greater than 30. degree. C. , b) mixing this solution with an aqueous solution of a protective colloid, the hydrophilic solvent component being transferred into the aqueous phase, and the hydrophobic phase of the lycopene resulting as a nanodisperse phase, c) and freeing the formed dispersion from the solvent and the water for the preparation of a water-dispersible dry powder and, if appropriate, drying in the presence of a coating material. 2. A process as claimed in claim 1, wherein in step a) the molecularly disperse lycopene solution is prepared at temperatures from 50 to 240. degree. C. and immediately subsequently mixed with the aqueous solution of the protective colloid in step b, a mixing temperature of approximately 35 to 80. degree. C. being set. 3. A pulverulent lycopene formulation prepared by a process as claimed in claim 1, comprising lycopene having a degree of crystallinity of greater than 20%. 4. A lycopene formulation as claimed in claim 3, comprising 0. 5 to 25% by weight of lycopene, 10 to 50% by weight of a protective colloid, 20 to 70% by weight of a plasticizer, 0 to 10% by weight of a stabilizer, all percentage data based on the dry mass of the powder. 5. A lycopene formulation as claimed in claim 3, comprising lycopene having an all-trans isomer content of at least 50%. 6. A lycopene formulation as claimed in claim 3, comprising lycopene having a particle size of less than 10 . mu. m. 7. A lycopene formulation as claimed in claim 3, which is water-dispersible. 8. A process for the preparation of stable, aqueous lycopene dispersions, comprising lycopene having a degree of crystallinity of greater than 20%, which comprises a) preparing a molecularly disperse solution of lycopene, if appropriate together with an emulsifier and/or an edible oil in a water-miscible, organic solvent or a mixture of water and a water-miscible, organic solvent at temperatures of greater than 30
|
| Related patents |
|
|
Cosmetic compositions with agglomerated substrates
OF PREFERRED EMBODIMENTS Below, the invention is explained in more detail by means of examples. All percentage references relate to weight (mass) unless otherwise ...
|
|
|
Emulsifier-free finely disperse systems of the oil-in-water and water-in-oil type
The invention claimed is: 1. Pickering emulsions, which are finely disperse water-in-oil or oil-in-water systems, comprising (1) an oil phase, (2) an aqueous phase, (3) ...
|
|
|
Isolates of pythium species which are antagonistic to Pythium ultimum
What is claimed is: 1. A biologically pure culture of Pythium isolate N2 having the identifying characteristics of ATCC 20692. 2. A biologically pure culture of Pythium ...
|
|
|
Bacterial substance and pharmaceutical composition thereof
AND PREFERRED EMBODIMENT The term "treatment" used herein is intended to cover all the controls of diseases including prevention, sustention (i.e. prevention of ...
|
|
|
Compounds, compositions, and methods for controlling biofilms
This invention relates to compounds, compositions, and methods for controlling biofilms. "Controlling" a biofilm means disrupting a biofilm and/or preventing biofilm ...
|
|
|
Cosmetic make-up composition containing a fullerene or mixture of fullerenes as a pigmenting agent
I claim: 1. A cosmetic composition in the form of an oil-in-water or water-in-oil emulsion containing an effective amount of fullerene or mixture of fullerenes as a ...
|
|
|
Benzylidenenorcamphor derivatives
What is claimed is: 1. A method for screening the skin or hair from the sun comprising applying to the skin or hair a benzylidenenorcamphor compound of the formula I ##ST...
|
|
|
Cosmetic compositions comprising a film-forming polymer a citric acid ester and a plasticizing agent
We claim: 1. A cosmetic composition for forming a film on skin, eyelashes, eyebrows, hair, or nails comprising: (a) at least one film-forming polymer; (b) at least one ...
|
|
|
Triazine derivatives
What is claimed is: 1. A cosmetic preparation, comprising at least one triazine compound of the formula ##STR60## in which R is halogen; straight-chain or branched C.sub....
|
|
|
Chlorite in the treatment of neurodegenerative disease
The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or ...
|
|
|